Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Heim

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
European Journal of Internal Medicine|August 8, 2017
Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?Audrey Benyamine, Daniel Bertin, Xavier Heim, et al.
Frontiers in Immunology|August 22, 2025
Antiphospholipid antibodies during acute COVID-19 are not associated with long COVID: findings from a retrospective cohort studyRobin Arcani, Alexandre Brodovitch, Xavier Heim, et al.
La Revue De Medecine Interne|February 14, 2025
[A transient electrophoresis peak]Quentin Gomes de Pinho, Xavier Heim, Gabriel Dejeans, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 31, 2020
ReplyDaniel Bertin, Alexandre Brodovitch, Abdelouahab Beziane, et al.
Expert Review of Respiratory Medicine|May 13, 2020
Lung involvement associated with anti-NXP2 autoantibodies in inflammatory myopathies: a French monocenter seriesJulien Bermudez, Xavier Heim, Daniel Bertin, et al.
Biomedicines|July 27, 2024
Deciphering the Reactivity of Autoantibodies Directed against the RNP-A, -C and 70 kDa Components of the U1-snRNP Complex: "Double or Nothing"?Daniel Bertin, Benjamin Babacci, Alexandre Brodovitch, et al.
International Journal of Molecular Sciences|January 21, 2023
Signaling Pathways and Potential Therapeutic Strategies in Cardiac FibrosisAlexandrine Bertaud, Ahmad Joshkon, Xavier Heim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2020
Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 SeverityDaniel Bertin, Alexandre Brodovitch, Abdou Beziane, et al.
Rheumatology International|February 19, 2018
Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the diseaseAudrey Benyamine, Xavier Heim, Noémie Resseguier, et al.
Journal of Thrombosis and Haemostasis : JTH|September 1, 2021
Single or triple positivity for antiphospholipid antibodies in "carriers" or symptomatic patients: Untangling the knotDaniel Bertin, Laurence Camoin-Jau, Véronique Veit, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Internal Medicine|August 8, 2017
Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?Audrey Benyamine, Daniel Bertin, Xavier Heim, et al.
Frontiers in Immunology|August 22, 2025
Antiphospholipid antibodies during acute COVID-19 are not associated with long COVID: findings from a retrospective cohort studyRobin Arcani, Alexandre Brodovitch, Xavier Heim, et al.
La Revue De Medecine Interne|February 14, 2025
[A transient electrophoresis peak]Quentin Gomes de Pinho, Xavier Heim, Gabriel Dejeans, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 31, 2020
ReplyDaniel Bertin, Alexandre Brodovitch, Abdelouahab Beziane, et al.
Expert Review of Respiratory Medicine|May 13, 2020
Lung involvement associated with anti-NXP2 autoantibodies in inflammatory myopathies: a French monocenter seriesJulien Bermudez, Xavier Heim, Daniel Bertin, et al.
Biomedicines|July 27, 2024
Deciphering the Reactivity of Autoantibodies Directed against the RNP-A, -C and 70 kDa Components of the U1-snRNP Complex: "Double or Nothing"?Daniel Bertin, Benjamin Babacci, Alexandre Brodovitch, et al.
International Journal of Molecular Sciences|January 21, 2023
Signaling Pathways and Potential Therapeutic Strategies in Cardiac FibrosisAlexandrine Bertaud, Ahmad Joshkon, Xavier Heim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2020
Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 SeverityDaniel Bertin, Alexandre Brodovitch, Abdou Beziane, et al.
Rheumatology International|February 19, 2018
Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the diseaseAudrey Benyamine, Xavier Heim, Noémie Resseguier, et al.
Journal of Thrombosis and Haemostasis : JTH|September 1, 2021
Single or triple positivity for antiphospholipid antibodies in "carriers" or symptomatic patients: Untangling the knotDaniel Bertin, Laurence Camoin-Jau, Véronique Veit, et al.
Pageof 3